• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈癌患者的细胞介导免疫反应。

Cell-mediated immune response in head and neck cancer patients.

作者信息

Olivari A, Pradier R, Feierstein J, Guardo A, Glait H, Rojas A

出版信息

J Surg Oncol. 1976;8(4):287-94. doi: 10.1002/jso.2930080405.

DOI:10.1002/jso.2930080405
PMID:781404
Abstract

The immune reactivity of 100 head and neck cancer patients was studied by means of DNCB, candidine, blastic transformation with PHA, and lymphocyte counts. DNCB reactivity was strong in only 21% of the population and was found impaired in patients with advanced primitive tumors, with more than one primitive tumor, and in patients after radiation. Candidine reactivity was impaired in bigger primitive tumors, positive nodes, and advanced stages, as well as in postradiation patients. Blastic transformation was significantly worse in patients over 70 years and tended to be lower in patients with more than one primitive tumor. Good blastic transformation was also lowered in postradiation patients.

摘要

通过二硝基氯苯(DNCB)、白假丝酵母菌、PHA诱导的淋巴细胞转化及淋巴细胞计数等方法,对100例头颈癌患者的免疫反应性进行了研究。仅21%的患者DNCB反应性较强,且在晚期原发性肿瘤患者、有多个原发性肿瘤的患者以及放疗后的患者中发现其反应性受损。在较大的原发性肿瘤、阳性淋巴结、晚期患者以及放疗后的患者中,白假丝酵母菌反应性受损。70岁以上患者的淋巴细胞转化明显较差,且有多个原发性肿瘤的患者其淋巴细胞转化往往较低。放疗后患者的良好淋巴细胞转化也降低。

相似文献

1
Cell-mediated immune response in head and neck cancer patients.头颈癌患者的细胞介导免疫反应。
J Surg Oncol. 1976;8(4):287-94. doi: 10.1002/jso.2930080405.
2
Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.头颈部鳞状细胞癌患者治疗前的非特异性细胞免疫
J Maxillofac Surg. 1978 May;6(2):75-93. doi: 10.1016/s0301-0503(78)80074-5.
3
Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.头颈部鳞状细胞癌中的免疫反应性及其与免疫治疗试验设计的相关性。
Semin Oncol. 1977 Dec;4(4):431-9.
4
Dinitrochlorobenzene skin sensitization and peripheral lymphocyte count: predictors of survival in head and neck cancer.二硝基氯苯皮肤致敏作用与外周淋巴细胞计数:头颈部癌症生存的预测指标
Ann Otol Rhinol Laryngol. 1976 Jul-Aug;85(4 Pt 1):517-22. doi: 10.1177/000348947608500413.
5
Immunologic evaluation and prognosis in patients with head and neck cancer.头颈部癌患者的免疫学评估与预后
Am J Surg. 1977 Oct;134(4):468-73. doi: 10.1016/0002-9610(77)90380-4.
6
The usefulness of pretreatment DNCB in 85 patients with squamous cell carcinoma of the upper aerodigestive tract.85例上消化道鳞状细胞癌患者术前使用二硝基氯苯的效用。
J Surg Oncol. 1978;10(1):73-7. doi: 10.1002/jso.2930100112.
7
[Determination of cellular immunity in patients with malignant tumors].[恶性肿瘤患者细胞免疫的测定]
Rev Laryngol Otol Rhinol (Bord). 1976 Sep-Oct;97(9-10):387-96.
8
[Investigations of unspecific immune reactivity in patients with head and neck carcinoma (author's transl)].头颈部癌患者非特异性免疫反应的研究(作者译)
Arch Otorhinolaryngol. 1981;232(2):145-63. doi: 10.1007/BF00505034.
9
Cellular immunity in patients with epidermoid cancer of the head and neck.头颈部表皮样癌患者的细胞免疫
Laryngoscope. 1979 Apr;89(4):538-49. doi: 10.1288/00005537-197904000-00002.
10
Immunologic evaluation of patients with advanced head and neck cancer receiving weekly chemoimmunotherapy.
Cancer. 1979 Jul;44(1):117-23. doi: 10.1002/1097-0142(197907)44:1<117::aid-cncr2820440121>3.0.co;2-q.